Unrecognized Attention-Deficit/Hyperactivity Disorder in Adults Presenting with Other Psychiatric Disorders

CNS Spectrums

Volumn 13, Issue 11, 2008, Pages 977-984

  Barkley, Russell A ^a   Brown, Thomas E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Yale New Haven Psychiatric Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HOSPITALIZATION; HUMAN; MENTAL DISEASE; META ANALYSIS; NEUROPSYCHOLOGICAL TEST; PREVALENCE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERRORS; HUMANS; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 60249090157     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900014036     Document Type: Review

References (66)

1. Barkley, RA, Murphy, KR, Fischer, M. Identifying new symptoms for ADHD in adulthood. In: ADHD in Adults: What the Science Tells Us. New York, NY: Guilford Press; 2008: 170–204.
2. Brown, T. Attention Deficit Disorder: The Unfocused Mind in Children and Adults. New Haven, CT: Yale University Press; 2005.
3. Biederman, J, Faraone, SV. Attention-deficit hyperactivity disorder. Lancet, 2005; 366: 237–248.
4. Polanczyk, G, de Lima, MS, Horta, BL, Biederman, J, Rohde, LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164: 942–948.
5. Faraone, SV, Sergeant, J, Gillberg, C, Biederman, J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003; 2: 104–113.
6. Faraone, SV, Biederman, J, Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006; 36: 159–165.
7. Kessler, RC, Adler, L, Barkley, R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163: 716–723.
8. Milberger, S, Biederman, J, Faraone, SV, Murphy, J, Tsuang, MT. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms. Am J Psychiatry. 1995; 152: 1793–1799.
9. Barkley, RA, Murphy, KR, Fischer, M. Comorbid psychiatric disorders and psychological maladjustment. In: ADHD in Adults: What the Science Tells Us. New York, NY: Guilford Press; 2008: 205–244.
10. Robison, LM, Skaer, TL, Sclar, DA. Is attention-deficit hyperactivity disorder (ADHD) diagnosed in adults? An examination of US office-based physician visits, 1995-2000. Int J Pharm Med. 2004; 18: 337–341.
11. Nierenberg, AA, Miyahara, S, Spencer, T, et al, for STEP-DB Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005; 57: 1467–1473.
12. Steinhoff, KW. Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action. Am J Manag Care. 2004; 10: S99–S106.
13. Brown, TE. DSM-IV: ADHD and executive function impairments. Adv Stud Med. 2002; 2: 910–914.
14. Barkley, RA, Biederman, J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1997; 36: 1204–1210.
15. Barkley, RA, Murphy, KR, Fischer, M. Diagnostic criteria for ADHD in adults. In: ADHD in Adults: What the Science Tells Us. New York, NY: Guilford Press; 2008: 26–40.
16. Disorders usually first diagnosed in infancy, childhood, or adolescence. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association. 2000: 85–102.
17. Faraone, SV, Biederman, J, Spencer, T, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006; 163: 1720–1729.
18. Castellanos, FX, Sonuga-Barke, EJ, Milham, MP, Tannock, R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci. 2006; 10: 117–123.
19. Biederman, J, Mick, E, Faraone, SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000; 157: 816–818.
20. Stavro, GM, Ettenhofer, ML, Nigg, JT. Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc. 2007; 13: 324–334.
21. Hart, EL, Lahey, BB, Loeber, R, Applegate, B, Frick, PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol. 1995; 23: 729–749.
22. Biederman, J, Faraone, SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed. 2006; 8: 12.
23. Barkley, RA, Fischer, M, Smallish, L, Fletcher, K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006; 45: 192–202.
24. Barkley, RA, Murphy, KR, DuPaul, GJ, Bush, T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc. 2002; 8: 655–672.
25. Barkley, RA, Murphy, KR, Fischer, M. Health, lifestyle, money management, and driving. In: ADHD in Adults: What the Science Tells Us. New York, NY: Guilford Press; 2008: 330–376.
26. Brown, TE. Executive functions and attention deficit hyperactivity disorder: implications of two conflicting views. Int J Disability Develop Educ. 2006; 53: 35–46.
27. Weiss, MD, Weiss, JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004; 65(suppl 3):27–37.
28. Barkley, RA, Murphy, KR, Fischer, M. Neuropsychological functioning. In: ADHD in Adults: What the Science Tells Us. New York, NY: Guilford Press; 2008: 400–433.
29. Hervey, AS, Epstein, JN, Curry, JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004; 18: 485–503.
30. Burgess, PW. Theory and methodology in executive function research. In: Rabbit, P, ed. Methodology of Frontal and Executive Function. New York, NY: Kluwer Academic/Plenum Publishers; 1997: 81–116.
31. Barkley, RA, Fischer, M, Smallish, L, Fletcher, K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002; 111: 279–289.
32. DuPaul, GJ, Power, TJ, Anastopoulos, AD, Reid, R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 1998.
33. Murphy, KR, Adler, LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry. 2004; 65(suppl 3):12–17.
34. Kooij, JJS, Marije Boonstra, A, Swinkels, SH, et al. Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. J Atten Disord. 2008; 11: 445–458.
35. Lomas, B, Gartside, P. ADHD in adult psychiatric outpatients. Psychiatr Serv. 1999; 50: 705.
36. Murphy, K, Barkley, RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996; 37: 393–401.
37. Alpert, JE, Maddocks, A, Nierenberg, AA, et al. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996; 62: 213–219.
38. Hesslinger, B, Tebartz van Elst, L, Mochan, F, Ebert, D. A psychopathological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent brief depression. Acta Psychiatr Scand. 2003; 107: 385–389.
39. Fishman, PA, Stang, PE, Hogue, SL. Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry. 2007; 68: 248–253.
40. Adler, LA, Sitt, DJ, Nierenberg, A. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Poster presented at: Annual Meeting of the American Academy of Child and Adolescent Psychiatry. October 24-29, 2006; San Diego, Calif.
41. Fischer, AG, Bau, CH, Grevet, EH, et al. The role of comorbid major depressive disorder in the clinical presentation of adult ADHD. J Psychiatr Res. 2007; 41: 991–996.
42. Kessler, RC, Berglund, P, Dernier, O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62: 593–602.
43. Biederman, J, Faraone, S, Mick, E, et al. Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Psychiatry. 1996; 35: 997–1008.
44. Sachs, GS, Baldassano, CF, Truman, CJ, Guille, C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry. 2000; 157: 466–468.
45. Schubiner, H, Tzelepis, A, Milberger, S, et al. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000; 61: 244–251.
46. Gordon, SM, Tulak, F, Troncale, J. Prevalence and characteristics of adolescent patients with co-occurring ADHD and substance dependence. J Addict Dis. 2004; 23: 31–40.
47. Carroll, KM, Rounsaville, BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry. 1993; 34: 75–82.
48. Wilens, TE, Dodson, W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry. 2004; 65: 1301–1313.
49. Saules, KK, Pomerleau, CS, Schubiner, H. Patterns of inattentive and hyperactive symptomatology in cocaine-addicted and non-cocaine-addicted smokers diagnosed with adult attention deficit hyperactivity disorder. J Addict Dis. 2003; 22: 71–78.
50. Biederman, J, Monuteaux, MC, Spencer, T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008; 165: 597–603.
51. Manassis, K, Tannock, R, Young, A, Francis-John, S. Cognition in anxious children with attention deficit hyperactivity disorder: a comparison with clinical and normal children. Behav Brain Fund. 2007; 3: 4.
52. August, GJ, Winters, KC, Realmuto, GM, et al. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006; 45: 824–832.
53. Newcorn, JH, Halperin, JM. Attention-deficit disorders with oppositionality and aggression. In: Brown, TE, ed, Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press, Inc.; 2000: 171–205.
54. Mannuzza, S, Klein, RG, Bonagura, N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry. 1991; 48: 77–83.
55. Wilens, TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am. 2004; 27: 283–301.
56. Wilens, TE, Biederman, J, Prince, J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996; 153: 1147–1153.
57. Spencer, T, Biederman, J, Wilens, T, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57: 456–463.
58. CME Institute of Physicians Postgraduate Press I. Managing ADHD in children, adolescents, and adults with comorbid anxiety. J Clin Psychiatry. 2007; 68: 451–462.
59. Spencer, TJ, Faraone, SV, Michelson, D, et al. Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J Clin Psychiatry. 2006; 67: 415–420.
60. Biederman, J, Spencer, TJ, Newcorn, JH, et al. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl). 2007; 190: 31–41.
61. Newcorn, JH, Spencer, TJ, Biederman, J, Milton, DR, Michelson, D. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005; 44: 240–248.
62. Hazell, P, Zhang, S, Wolanczyk, T, et al. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2006; 15: 105–110.
63. Pelham, WE, Gnagy, EM, Burrows-Maclean, L, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001; 107: E105.
64. Spencer, TJ, Abikoff, HB, Connor, DF, et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther. 2006; 28: 402–418.
65. Klein, RG, Abikoff, H, Klass, E, Ganeles, D, Seese, LM, Pollack, S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry. 1997; 54: 1073–1080.
66. Pliszka, SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998; 59(suppl 7):50–58.